Dow Jones

40 833,35

1,55%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Italie
BIT
Abitare In Spa (ABT)
Abitare In Spa (ABT) Actualités

ABT

Abitare In (ABT)

Abitare In Spa

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:BIT:ABT

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
24/08/2005	14h00	PR Newswire (US)	Wal-Mart Hosts Child Safety Education Event Nationwide	NYSE:ABT
09/07/2005	07h21	PR Newswire (US)	Abbott Statement on Agreement With Brazilian Government for Kaletra(R) (Lopinavir/Ritonavir)	NYSE:ABT
14/06/2005	23h00	PR Newswire (US)	Getting Arms Around Childhood Obesity Focus of Colorado Summit	NYSE:ABT
10/06/2005	18h54	PR Newswire (US)	Abbott Declares 326th Consecutive Quarterly Dividend	NYSE:ABT
12/05/2005	17h55	PR Newswire (US)	Recent College Graduates Find Success at Abbott	NYSE:ABT
27/04/2005	17h00	PR Newswire (US)	Creative Way to Calm a Fussy Baby May Win a 'Fuss-Free' Trip For Mom	NYSE:ABT
11/04/2005	20h00	PR Newswire (US)	Abbott Named No. 5 to DiversityInc's Top 50 Companies for Diversity list	NYSE:ABT
05/04/2005	14h00	PR Newswire (US)	Abbott Joins National Program to Help Millions of Uninsured Americans Get the Prescription Medicines They Need	NYSE:ABT
11/02/2005	21h12	PR Newswire (US)	FDA Agrees to File Abbott's New Drug Application for Xinlay(TM) (Atrasentan) to Treat Metastatic Hormone-Refractory Prostate Can	NYSE:ABT
25/01/2005	16h00	PR Newswire (US)	FDA Approves First Gene-Based Test, UroVysion(TM), for Diagnosis of Patients Suspected of Having Bladder Cancer	NYSE:ABT
15/12/2004	17h55	PR Newswire (US)	TAP Submits New Drug Application for Febuxostat for the Management of Hyperuricemia in Chronic Gout	NYSE:ABT
01/11/2004	17h24	PR Newswire (US)	Longest Study of Kaletra(R) (Lopinavir/Ritonavir) Based Regimen Demonstrated Favorable Resistance Profile for Patients Through S	NYSE:ABT
01/11/2004	16h00	PR Newswire (US)	/C O R R E C T I O N -- Abbott Laboratories/	NYSE:ABT
28/10/2004	20h00	PR Newswire (US)	Superstar Patti LaBelle Encourages Americans to Manage Diabetes 365 Days a Year	NYSE:ABT
15/09/2004	17h00	PR Newswire (US)	Abbott's On-Site Child Care Center Recognized Amongst the Country's Best	NYSE:ABT
27/07/2004	17h00	PR Newswire (US)	Abbott Laboratories Introduces First Fully Automated Test for Hepatitis A Virus	NYSE:ABT
14/07/2004	23h14	PR Newswire (US)	U.S. District Court Dismisses Claims Against Abbott Laboratories' Anti-Obesity Medication Meridia(R) (Sibutramine HCL Monohydrat	NYSE:ABT
14/07/2004	15h30	PR Newswire (US)	Kaletra(R) (lopinavir/ritonavir) Based Regimens Demonstrate Favorable Resistance in Clinical Trials	NYSE:ABT
24/06/2004	05h08	PR Newswire (US)	U.S. Food and Drug Administration (FDA) Denies Abbott's Citizen Petition Regarding Levothyroxine Sodium Products	NYSE:ABT
22/06/2004	16h00	PR Newswire (US)	New Campaign Aims to Inspire People With Diabetes to Experience 'Diabetes Freedom'	NYSE:ABT
11/06/2004	02h24	PR Newswire (US)	Abbott Laboratories' Statement Regarding FDA'S DDMAC Letter on Norvir(R) (Ritonavir Capsules) Materials	NYSE:ABT
10/06/2004	15h00	PR Newswire (US)	ReAct Study Shows Abbott's Humira(R) (Adalimumab) Significantly Reduces Signs and Symptoms in Patients Battling Rheumatoid Arthr	NYSE:ABT
07/06/2004	16h01	PR Newswire (US)	Abbott and Protein Design Labs Announce Broad, Long-Term Collaboration for Humanized Therapeutic Antibodies	NYSE:ABT
06/06/2004	00h30	PR Newswire (US)	Meta-Analysis Results Presented at ASCO Show Statistically Significant Delay in Time to Disease Progression for Advanced Prostat	NYSE:ABT
01/06/2004	16h30	PR Newswire (US)	Abbott Laboratories Introduces 10 Clinical Chemistry Tests	NYSE:ABT
27/05/2004	16h30	PR Newswire (US)	Abbott Laboratories' Zemplar(R) (Paricalcitol Injection) Receives FDA Approval for Pediatric Use	NYSE:ABT
26/05/2004	20h00	PR Newswire (US)	Data Demonstrate Impact of Weight Loss With Sibutramine on Cardiovascular Risk Factors for Obese Patients	NYSE:ABT
14/05/2004	01h37	PR Newswire (US)	Abbott Laboratories to Present at Banc of America Securities Health Care Conference	NYSE:ABT
06/05/2004	13h00	PR Newswire (US)	Abbott Laboratories Receives Positive Opinion for HUMIRA(R) Rheumatoid Arthritis Label Extension From European Medicines Evaluat	NYSE:ABT
13/04/2004	19h20	PR Newswire (US)	Rheumatoid Arthritis Awareness Campaign Plants a 'Can-Do' Spirit in Patients	NYSE:ABT